Participation in the Cell Therapy Manufacturing Asia Forum in Japan
Dr. Hsiu-Ling Hsiao, as the Chief Scientist Officer (CSO) of Ever Supreme Bio Technology (ESBT) had the honor to be invited to participate as a speaker and lead discussion at the research forum of Cell Therapy Manufacturing Asia at Kyoto, Japan from Feb. 27 to Mar. 02. Her speech focused on the logistics for the latest cell preparation, supply chain and skill strategies of cryopreservation. It was well received by the participants and highly commended by the organizer who expressed keen interest to invite Dr. Hsiao for future involvements again.
The Kyoto forum on the Cell Therapy industry was attended by the leading academia and scientists around the globe, including Europe, North America and Asia. In the forum, renowned experts shared their knowledge and experiences which enabled participants to expand their horizon of new technologies and enhanced their professionalism in the field. The host Cell Therapy Manufacturing Asia is an active, respected and influential player in the arena of cell therapies. This time, ESBT is honored to be invited to contribute in the discussion and sharing of biopharmaceutical experiences from Taiwan. In accordance with its mission, ESBT will continue to dedicate its resources and efforts in the research and development of innovative and effective cell therapy drugs, and correspond with international experts in the field to contribute to the great cause of curing human diseases.